🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesEchocardiographic changes on GLP-1 — November 2025 Page 3

Echocardiographic changes on GLP-1 — November 2025

NeuroNate Sat, Mar 14, 2026 at 8:34 PM 29 replies 1,138 viewsPage 3 of 6
amsterdam_pete
Senior Member
1,567
6,789
Feb 2024
Netherlands
Mar 15, 2026 at 8:59 AM#11
DebRD_ATL said:
Vitamin deficiency cascade with cardiovascular risk: after 6+ months of reduced food intake, I developed a subtle but important pattern: low B12 →…

Senior perspective on cardiovascular risk: I'm 62 years old and started this journey skeptically. My internist recommended it after years of failed interventions.

12 months later: down 50 lbs, more mobile, pain reduced, medications simplified. My quality of life has improved dramatically. I wish this existed 20 years ago.

To other older adults hesitating: the SELECT trial proved benefit in our age group. You deserve to feel good in your body regardless of age.

35 8JakeSmashed95, NauseaFreeNow, SteveThurs and 32 others
Reply Quote Save Share Report
carlos_SATX
Member
245
1,123
Oct 2024
San Antonio, TX
Mar 15, 2026 at 11:13 AM#12
rachel_ABQ said:
Continuous metabolic monitoring dashboard for cardiovascular risk — I track everything in a spreadsheet and here's the month-over-month trend for my…

Thank you — that is the clearest version of this I have read, and I have read a lot of them. I will report back once I have actually tried it.

36 9FranDenver, Dr.BariatricHTX, LindaRN_retired and 33 others
Reply Quote Save Share Report
HealthEcon_DC
Member
567
3,456
Apr 2024
Washington, DC
Mar 15, 2026 at 1:27 PM#13
DebRD_ATL said:
Vitamin deficiency cascade with cardiovascular risk: after 6+ months of reduced food intake, I developed a subtle but important pattern: low B12 →…

Dizziness and cardiovascular risk: I was lightheaded for the first 2 weeks. Root cause was a combination of reduced caloric intake and mild dehydration.

Fix: minimum 80-100oz water daily, don't skip meals even if you're not hungry (eat small protein-rich snacks), and stand up slowly from sitting/lying positions. Also check your blood pressure — GLP-1-induced weight loss can make BP meds too strong, requiring dose reduction.

37 10KevinCompounds, TirzTom, TrialTracker_MD and 34 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
DoseLogDan
Member
201
567
Feb 2025
Montana
Mar 15, 2026 at 3:41 PM#14
NeuroNate said:
My reason for being on this is cardiovascular rather than cosmetic, which puts me in a small minority in most of these threads.

Positive "side effect" of cardiovascular risk: my blood pressure dropped so much that I'm now off metoprolol entirely! My cardiologist is thrilled.

If you're on BP meds and losing weight on a GLP-1, monitor your BP at home regularly. Hypotension symptoms (dizziness, lightheadedness when standing) mean your BP meds may need reduction. Don't wait for your next scheduled appointment — call your doctor.

38 11sophie_paris, mel_PDX, Dr.AddMedPHL and 35 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Mar 15, 2026 at 5:55 PM#15

Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful.

39 12PurityPaulOR, MaxMetOK, MounjBrad and 36 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register